Expressions and clinical significance of HER4 and CD44 in sinonasal mucosal malignant melanoma
Authors:
- 1 April 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 28 (2) , 105-110
Abstract
Sinonasal mucosal malignant melanoma (SNMMM) is a rare disease. The aim of this study was to investigate the expressions of HER4 and CD44 in human SNMMM tissues and their relationship with the clinicopathological features and prognosis of patients. In total, 64 paraffin-embedded samples of SNMMM treated in our hospital from 29 December 1999 to 24 June 2011 were collected. HER4 and CD44 were detected in the tissues of SNMMM by immunohistochemistry. The differences in the HER4 and CD44 expressions in the tissues were evaluated and matched with clinicopathological parameters and the survival rate, respectively. The positive rates of the HER4 and CD44 expressions were 70.3 and 65.6%, respectively; the positive expression of HER4 was correlated with a positive expression of CD44 (PP0.05). The expressions of HER4 and CD44 were not significantly correlated with sex, age, pigment, tumor site, etc. (P>0.05). Our results further emphasize a correlation between HER4 and CD44 expressions in SNMMM tissues and point out that a positive HER4 expression might be an important factor in valuing the prognosis of patients with SNMMM.Keywords
This publication has 33 references indexed in Scilit:
- Clinicopathological Features and Prognosis of Sinonasal Mucosal Malignant Melanoma: A Retrospective Study of 83 Cases in a Chinese PopulationORL, 2016
- Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neckMelanoma Research, 2015
- Postoperative Adjuvant Radiation Therapy in the Treatment of Primary Head and Neck Mucosal MelanomasORL, 2008
- Correlated Expression of erbB-3 With Hormone Receptor Expression and Favorable Clinical Outcome in Invasive Ductal Carcinomas of the BreastAmerican Journal of Clinical Pathology, 2007
- Gene copy numbers of HER family in breast cancerJournal of Cancer Research and Clinical Oncology, 2007
- PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomasBritish Journal of Cancer, 2007
- The ERBB4/HER4 Intracellular Domain 4ICD Is a BH3-Only Protein Promoting Apoptosis of Breast Cancer CellsCancer Research, 2006
- Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neckHead & Neck, 2004
- Cancer of the Nasal CavityJAMA Otolaryngology–Head & Neck Surgery, 2002
- Secondary Malignant Melanoma of the LarynxORL, 1984